Torsdag 5 December | 07:10:06 Europe / Stockholm

Prenumeration

Kalender

Tid*
2024-10-18 - Kvartalsrapport 2024-Q3
2024-08-16 - Kvartalsrapport 2024-Q2
2024-05-06 - X-dag ordinarie utdelning MODU 0.00 EUR
2024-04-26 - Kvartalsrapport 2024-Q1
2024-02-23 - Bokslutskommuniké 2023
2023-10-20 - 15-10 2023-Q3
2023-08-18 - Kvartalsrapport 2023-Q2
2023-05-03 - X-dag ordinarie utdelning MODU 0.00 EUR
2023-05-02 - Årsstämma
2023-04-28 - 15-10 2023-Q1
2023-02-23 - Bokslutskommuniké 2022
2022-08-19 - Kvartalsrapport 2022-Q2
2022-05-03 - X-dag ordinarie utdelning MODU 0.00 EUR
2022-05-02 - Årsstämma

Beskrivning

LandFinland
ListaFirst North Finland
SektorHälsovård
IndustriMedicinteknik
Modulight är verksamt inom teknikbranschen. Bolaget designar, marknadsför och producerar biomedicinska laserprodukter som används inom onkologi, genetik och oftalmologi. Kunderna består primärt av sjukhus och företagskunder verksamma inom medicinteknik. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Störst verksamhet återfinns inom Europa.
2022-10-13 07:00:00

Modulight Corporation Press release October 13, 2022, at 08:00 a.m. EEST

Modulight Corporation will publish its 3Q22 business review on October 20, 2022, approximately at 08:00 a.m. EEST.

Modulight's CEO Seppo Orsila will present the result in an English-language webcast, which will be held on October 20, 2022 at 10:30 a.m. EEST. The broadcast can be followed at https://modulight.videosync.fi/q3-2022-results.

Questions are to be submitted in writing in the webcast portal. CFO Anca Guina will also be present to answer questions.

Presentation materials will be available before the start of the event on the company’s website at www.modulight.com/reports-presentations/

For further information, please contact:

CEO Seppo Orsila, m. +358 40 830 4671
Investor relations: Ulla Haapanen, m. +358 40 830 4676
email: ir@modulight.com

Certified adviser: Danske Bank A/S, Finland Branch, m. +358 40 414 5358

www.modulight.com
Twitter: @modulight

Modulight in brief

Modulight Corporation is a biomedical laser company that designs and manufactures products for oncology, ophthalmology and genetics. The company also provides solutions for selected high value-add applications including quantum computing and digital press. The company’s products include medical devices, subsystems, software, cloud services and specialized semiconductors. Modulight’s products are used worldwide by many Fortune 500 companies, pharmaceutical companies, and well-known cancer centers and universities. Modulight was founded in 2000 and is headquartered in Tampere, Finland. www.modulight.com

Follow Modulight: Twitter | LinkedIn | Facebook | YouTube | Instagram | #killcancer #laserfamily